Blockade of substance P receptor attenuates osteoporotic pain, but not bone loss, in ovariectomized mice

Menopause

Volumn 20, Issue 10, 2013, Pages 1074-1083

  Zheng, Xin Feng ^a   Li, Bo ^a   Zhang, Yue Hui ^a   Yang, Yue Hua ^a   Meng, Xiang Yu ^b   Jiang, Sheng Dan ^a   Jiang, Lei Sheng ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Hyperalgesia; NK1 receptor; Osteoporosis; Ovariectomy; Substance P

Indexed keywords

2 BENZHYDRYL 3 (2 IODOBENZYLAMINO)QUINUCLIDINE; SUBSTANCE P ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE METABOLISM; CONTROLLED STUDY; DORSAL ROOT; FEMALE; GANGLION; HYPERALGESIA; LUMBAR VERTEBRA; MOUSE; NONHUMAN; OSTEOLYSIS; OSTEOPOROTIC PAIN; OVARIECTOMY; PAIN; PAIN ASSESSMENT; PAIN THRESHOLD; SPINAL CORD; TIBIA;

ANALGESIA; ANALGESICS; ANIMALS; FEMALE; MICE; MICE, INBRED C57BL; NEUROKININ-1 RECEPTOR ANTAGONISTS; OSTEOPOROSIS; OVARIECTOMY; PAIN; QUINUCLIDINES; RECEPTORS, NEUROKININ-1;

EID: 84885178131     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/GME.0b013e31828837a6     Document Type: Article

References (63)

1. Cascieri MA, Huang RR, Fong TM, et al. Determination of the amino acid residues in substance P conferring selectivity and specificity for the rat neurokinin receptors. Mol Pharmacol 1992;41: 1096-1099.
2. ö ztürk N, Erin N, Tüzüner S. Changes in tissue substance P levels in patients with carpal tunnel syndrome. Neurosurgery 2010;67: 1655-1661.
3. Hong SK, Han JS, Min SS, et al. Local neurokinin-1 receptor in the knee joint contributes to the induction, but not maintenance, of arthritic pain in the rat. Neurosci Lett 2002;322: 21-24.
4. Sahbaie P, Shi X, Guo TZ, et al. Role of substance P signaling in enhanced nociceptive sensitization and local cytokine production after incision. Pain 2009;145: 341-349.
5. Gradl G, Finke B, Schattner S, Gierer P, Mittlmeier T, Vollmar B. Continuous intra-arterial application of substance P induces signs and symptoms of experimental complex regional pain syndrome (CRPS) such as edema, inflammation and mechanical pain but no thermal pain. Neuroscience 2007;148: 757-765.
6. Wei T, Li WW, Guo TZ, et al. Post-junctional facilitation of substance P signaling in a tibia fracture rat model of complex regional pain syndrome type I. Pain 2009;144: 278-286.
7. Kingery WS. Role of neuropeptide, cytokine, and growth factor signaling in complex regional pain syndrome. Pain Med 2010;11: 1239-1250.
8. Kingery WS, Davies MF, Clark JD. A substance P receptor (NK1) antagonist can reverse vascular and nociceptive abnormalities in a rat model of complex regional pain syndrome type II. Pain 2003;104: 75-84.
9. Lee SE, Kim JH. Involvement of substance P and calcitonin geneYrelated peptide in development and maintenance of neuropathic pain from spinal nerve injury model of rat. Neurosci Res 2007;58: 245-249.
10. Sarajari S, Oblinger MM. Estrogen effects on pain sensitivity and neuropeptide expression in rat sensory neurons. Exp Neurol 2010;224: 163-169.
11. Liu D, Li H, Zhao CQ, Jiang LS, Dai LY. Changes of substance PYimmunoreactive nerve fiber innervation density in the sublesional bones in young growing rats at an early stage after spinal cord injury. Osteoporos Int 2008;19: 559-569.
12. Rude RK, Gruber HE, Norton HJ, Wei LY, Frausto A, Mills BG. Bone loss induced by dietary magnesium reduction to 10% of the nutrient requirement in rats is associated with increased release of substance P and tumor necrosis factor->. J Nutr 2004;134: 79-85.
13. Kingery WS, Offley SC, Guo TZ, Davies MF, Clark JD, Jacobs CR. A substance P receptor (NK1) antagonist enhances the widespread osteoporotic effects of sciatic nerve section. Bone 2003;33: 927-936.
14. Liu-Ambrose T, Eng JJ, Khan KM, Mallinson A, Carter ND, McKay HA. The influence of back pain on balance and functional mobility in 65- to 75-year-old women with osteoporosis. Osteoporos Int 2002;13: 868-873.
15. Sanoja R, Cervero F. Estrogen modulation of ovariectomy-induced hyperalgesia in adult mice. Eur J Pain 2008;12: 573-581.
16. Sanoja R, Cervero F. Estrogen-dependent abdominal hyperalgesia induced by ovariectomy in adult mice: a model of functional abdominal pain. Pain 2005;118: 243-253.
17. Chen Y, Cui Y, Lin JW, Xiang QL, Liu WF, Wang TH. Modulatory role of estradiol in nicotinic antinociception in adult female rats. Life Sci 2009;85: 91-96.
18. Fan X, Kim HJ, Warner M, Gustafsson JA. Estrogen receptor A is essential for sprouting of nociceptive primary afferents and for morphogenesis and maintenance of the dorsal horn interneurons. Proc Natl Acad Sci 2007;104: 13696-13701.
19. Mowa C. Substance P in the uterine cervix, dorsal root ganglia and spinal cord during pregnancy and the effect of estrogen on SP synthesis. Peptides 2003;24: 761-771.
20. Watanabe T, Matsumoto M, Toji S, Miyagawa I. Effects of estrogen on age-related changes in muscarinic responsiveness of the urinary bladder and lumbosacral dorsal root ganglion cells in female rats. Mol Cell Biochem 2008;318: 53-61.
21. Schmitt PM, Gohil K, Kaufman MP. Spinal estrogen attenuates the exercise pressor reflex but has little effect on the expression of genes regulating neurotransmitters in the dorsal root ganglia. J Appl Physiol 2006; 100: 958-964.
22. Ohtori S, Akazawa T, Murata Y, et al. Risedronate decreases bone resorption and improves low back pain in postmenopausal osteoporosis patients without vertebral fractures. J Clin Neurosci 2010;17: 209-213.
23. Moricke R, Rettig K, Bethke TD. Use of recombinant human parathyroid hormone(1-84) in patients with postmenopausal osteoporosis: a prospective, open-label, single-arm, multicentre, observational cohort study of the effects of treatment on quality of life and painVthe PROPOSE study. Clin Drug Investig 2011;31: 87-99.
24. Iwamoto J, Takeda T, Sato Y, Uzawa M. Effects of alendronate on metacarpal and lumbar bone mineral density, bone resorption, and chronic back pain in postmenopausal women with osteoporosis. Clin Rheumatol 2004;23: 383-389.
25. Takakuwa M, Iwamoto J. Elcatonin in combination with risedronate is more effective than risedronate alone for relieving back pain in postmenopausal women with osteoporosis. Biol Pharm Bull 2012;35: 1159-1165.
26. Schacht E, Ringe JD. Risk reduction of falls and fractures, reduction of back pain and safety in elderly high risk patients receiving combined therapy with alfacalcidol and alendronate: a prospective study. Arzneimittelforschung 2011;61: 40-54.
27. Sun HB, Liu Q, Guo MF, Zhang HP, Chen JC. Substance P stimulates differentiation of mice osteoblast through up-regulating the expression of Osterix. J Xi'an Jiaotong Univ 2009;30: 716-719.
28. Wang L, Zhao R, Shi X, et al. Substance P stimulates bone marrow stromal cell osteogenic activity, osteoclast differentiation, and resorption activity in vitro. Bone 2009;45: 309-320.
29. Goto T, Nakao K, Gunjigake KK, Kido MA, Kobayashi S, Tanaka T. Substance P stimulates late-stage rat osteoblastic bone formation through neurokinin-1 receptors. Neuropeptides 2007;41: 25-31.
30. Mori T, Ogata T, Okumura H, Shibata T, Nakamura Y, Kataoka K. Substance P regulates the function of rabbit cultured osteoclast; increase of intracellular free calcium concentration and enhancement of bone resorption. Biochem Biophys Res Commun 1999;262: 418-422.
31. Ding W-G, Zhang Z-M, Zhang Y-H, Jiang S-D, Jiang L-S, Dai L-Y. Changes of substance P during fracture healing in ovariectomized mice. Regul Pept 2010;159: 28-34.
32. Jiang SD, Shen C, Jiang LS, Dai LY. Differences of bone mass and bone structure in osteopenic rat models caused by spinal cord injury and ovariectomy. Osteoporos Int 2007;18: 743-750.
33. Lolignier S, Amsalem M, Maingret F, et al. Nav1.9 channel contributes to mechanical and heat pain hypersensitivity induced by subacute and chronic inflammation. PLoS One 2011;6:e23083.
34. Thorsell A, Schank JR, Singley E, Hunt SP, Heilig M. Neurokinin-1 receptors (NK1R:s), alcohol consumption, and alcohol reward in mice. Psychopharmacology 2010;209: 103-111.
35. Ryan PJ, Evans P, Gibson T, Fogelman I. Osteoporosis and chronic back pain: a study with single-photon emission computed tomography bone scintigraphy. J Bone Miner Res 1992;7: 1455-1460.
36. Zheng JH, Song XJ. AA-Afferents activate neurokinin-1 receptor in dorsal horn neurons after nerve injury. Neuroreport 2005;16: 715-719.
37. Beaujouan JC, Saffroy M, Torrens Y, Glowinski J. Different subtypes of tachykinin NK(1) receptor binding sites are present in the rat brain. J Neurochem 2000;75: 1015-1026.
38. Leger L, Gay N, Cespuglio R. Neurokinin NK1- and NK3- immunoreactive neurons in serotonergic cell groups in the rat brain. Neurosci Lett 2002;323: 146-150.
39. Pacharinsak C, Khasabov SG, Beitz AJ, Simone DA. NK-1 receptors in the rostral ventromedial medulla contribute to hyperalgesia produced by intraplantar injection of capsaicin. Pain (Comparative Study Research Support, NIH, Extramural) 2008;139: 34-46.
40. Holden JE, Pizzi JA. Lateral hypothalamic-induced antinociception may be mediated by a substance P connection with the rostral ventromedial medulla. Brain Res 2008;1214: 40-49.
41. Hamity MV, White SR, Hammond DL. Effects of neurokinin-1 receptor agonism and antagonism in the rostral ventromedial medulla of rats with acute or persistent inflammatory nociception. Neuroscience (Research Support, NIH, Extramural) 2010;165: 902-913.
42. Forman LJ, Tingle V, Estilow S, Cater J. The response to analgesia testing is affected by gonadal steroids in the rat. Life Sci 1989;45: 447-454.
43. Ito A, Kumamoto E, Takeda M, Shibata K, Sagai H, Yoshimura M. Mechanisms for ovariectomy-induced hyperalgesia and its relief by calcitonin: participation of 5-HT1AYlike receptor on C-afferent terminals in substantia gelatinosa of the rat spinal cord. J Neurosci 2000;20: 6302-6308.
44. Taleghany N, Sarajari S, DonCarlos LL, Gollapudi L, Oblinger MM. Differential expression of estrogen receptor > and A in rat dorsal root ganglion neurons. J Neurosci Res 1999;57: 603-615.
45. Rose'Meyer RB, Mellick AS, Garnham BG, Harrison GJ, Massa HM, Griffiths LR. The measurement of adenosine and estrogen receptor expression in rat brains following ovariectomy using quantitative PCR analysis. Brain Res Brain Res Protoc 2003;11: 9-18.
46. Mach DB, Rogers SD, Sabino MC, et al. Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur. Neuroscience 2002; 113: 155-166.
47. Serre CM, Farlay D, Delmas PD, Chenu C. Evidence for a dense and intimate innervation of the bone tissue, including glutamate-containing fibers. Bone 1999;25: 623-629.
48. Martin CD, Jimenez-Andrade JM, Ghilardi JR, Mantyh PW. Organization of a unique net-like meshwork of CGRP+ sensory fibers in the mouse periosteum: implications for the generation and maintenance of bone fracture pain. Neurosci Lett 2007;427: 148-152.
49. Togari A. Adrenergic regulation of bone metabolism: possible involvement of sympathetic innervation of osteoblastic and osteoclastic cells. Microsc Res Tech 2002;58: 77-84.
50. Asmus SE, Parsons S, Landis SC. Developmental changes in the transmitter properties of sympathetic neurons that innervate the periosteum. J Neurosci 2000;20: 1495-1504.
51. Burt-Pichat B. Dramatic decrease of innervation density in bone after ovariectomy. Endocrinology 2004;146: 503-510.
52. Onuoha GN, Alpar EK. Levels of vasodilators (SP, CGRP) and vasoconstrictor (NPY) peptides in early human burns. Eur J Clin Investig 2001; 31: 253-257.
53. Onuoha GN, Alpar EK. Elevation of plasma CGRP and SP levels in orthopedic patients with fracture neck of femur. Neuropeptides 2000;34: 116-120.
54. Alpar EK, Onuoha G, Killampalli VV, Waters R. Management of chronic pain in whiplash injury. J Bone Joint Surg Br. 2002;84: 807-811.
55. Schinkel C, Scherens A, Koller M, Roellecke G, Muhr G, Maier C. Systemic inflammatory mediators in post-traumatic complex regional pain syndrome (CRPS I)Vlongitudinal investigations and differences to control groups. Eur J Med Res 2009;14: 130-135.
56. Takeuchi H, Kawaguchi S, Ohwada O, et al. Plasma neuropeptides in patients undergoing lumbar discectomy. Spine 2007;32:E79-E84.
57. Carvalho B, Clark DJ, Angst MS. Local and systemic release of cytokines, nerve growth factor, prostaglandin E2, and substance P in incisional wounds and serum following cesarean delivery. J Pain 2008;9: 650-657.
58. Dalby PL, Ramanathan S, Rudy TE, Roy L, Amenta JS, Aber A. Plasma and saliva substance P levels: the effects of acute pain in pregnant and non-pregnant women. Pain 1997;69: 263-267.
59. Puttfarcken PS, Han P, Joshi SK, et al. A-995662 [(R)-8-(4-methyl-5-(4- (trifluoromethyl)phenyl)oxazol-2-ylamino)-1,2,3,4-tetrahydr onaphthalen-2- ol], a novel, selective TRPV1 receptor antagonist, reduces spinal release of glutamate and CGRP in a rat knee joint pain model. Pain 2010;150: 319-326.
60. Lai JP, Ho WZ, Yang JH, Wang X, Song L, Douglas SD. A non-peptide substance P antagonist down-regulates SP mRNA expression in human mononuclear phagocytes. J Neuroimmunol 2002;128: 101-108.
61. Andersson G, Danielson P, Alfredson H, Forsgren S. Presence of substance P and the neurokinin-1 receptor in tenocytes of the human Achilles tendon. Regul Pept 2008;150: 81-87.
62. Maghni K, Michoud MC, Alles M, et al. Airway smooth muscle cells express functional neurokinin-1 receptors and the nerve-derived preprotachykinin- A gene: regulation by passive sensitization. Am J Respir Cell Mol Biol 2003;28: 103-110.
63. Shanley L, Lear M, Davidson S, Ross R, MacKenzie A. Evidence for regulatory diversity and auto-regulation at the TAC1 locus in sensory neurones. J Neuroinflamm 2011;8: 10.